[StemCyte-KY] Announcement of obtaining CPA's internal control system project review assurance report

Key facts

  • [StemCyte-KY] Announcement of obtaining CPA's internal control system project review assurance report
  • Source: PR Times
  • Date: May 14, 2026

Direct answer

StemCyte-KY announced on May 14, 2026, that it has obtained an internal control project review report issued by a certified public accountant, in compliance with regulatory requirements. The report covers the period from January 1, 2025, to December 31, 2025. The CPA provided an unqualified opinion (unmodified conclusion), indicating that the company's internal control systems are operating effectively. The full report is available on the Market Observation Post System.

Citation
[StemCyte-KY] Announcement of obtaining CPA's internal control system project review assurance report (May 14, 2026), PR Times
Source
PR Times
Date
May 14, 2026
出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: May 14, 2026 at 09:00
  • 🔍 Collected: May 15, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 15, 2026 at 08:04 (3 min after Collected)
StemCyte-KY announced on May 14, 2026, that it has obtained an internal control project review report issued by a certified public accountant, in compliance with regulatory requirements. The report covers the period from January 1, 2025, to December 31, 2025. The CPA provided an unqualified opinion (unmodified conclusion), indicating that the company's internal control systems are operating effectively. The full report is available on the Market Observation Post System.

FAQ

What are the key facts in this article?

StemCyte-KY announced on May 14, 2026, that it has obtained an internal control project review report issued by a certified public accountant, in compliance with regulatory requirements. The report covers the period from January 1, 2025, to December 31, 2025. The CPA provided an unqualified opinion (unmodified conclusion), indicating that the company's internal control systems are operating effectively. The full report is available on the Market Observation Post System.

What is the direct answer?

StemCyte-KY announced on May 14, 2026, that it has obtained an internal control project review report issued by a certified public accountant, in compliance with regulatory requirements. The report covers the period from January 1, 2025, to December 31, 2025. The CPA provided an unqualified opinion (unmodified conclusion), indicating that the company's internal control systems are operating effectively. The full report is available on the Market Observation Post System.

What is the source and date?

PR Times: https://mops.twse.com.tw/material/twse-4178-2026-05-14-0195d6c2 | May 14, 2026

Back to Newsroom (90)